Johns Hopkins Kimmel Cancer Center experts at Sibley Memorial Hospital in Washington, D.C., and Suburban Hospital in Bethesda, Maryland, have vast expertise in managing all stages of lung cancers.
Novel Cancer Treatments and Research
Our lung cancer experts offer a range of treatment options, including chemotherapy and radiation, surgery, molecular targeted therapies, and immunotherapies, which stimulate the body’s natural immune system to better fight cancer. In fact, medical oncologists at Johns Hopkins led national clinical trials of anti-PD-1 checkpoint inhibitors for lung cancers that led to the U.S. Food and Drug Administration’s approval of the first immunotherapy treatments for lung cancers. Listen to medical oncologist Benjamin Levy discusses new treatment options for lung cancers.
Our experts devise personal treatment plans for patients that may include a combination of therapies. Patients can receive all of their care within the greater Washington region.
- Watch radiation oncologist Stephen Greco explains how he uses imaging technology to improve the treatment of lung cancer.
- Watch thoracic surgeon Stephen Broderick discusses lung-sparing and minimally invasive surgeries.
- Watch interventional pulmonologist Andrew Lerner discusses the multidisciplinary team the Johns Hopkins Kimmel Cancer Center.
- Watch interventional pulmonologist Andrew Lerner demonstrates using new technology to reach lesions in the lungs that cannot be reached using traditional techniques.
Johns Hopkins Science
Our lung cancer patients have access to novel clinical trials being directed by experts in Washington, D.C., as well as our flagship campus in East Baltimore. Our lung cancer specialists also have expertise in the management of lung cancers in patients who were not smokers. Many of these patients have genetic alterations in their cancers that make them eligible for certain clinical trials and targeted therapies.